Pancreatectomy; Hyperglycemia
8
0
1
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
40%
2 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (8)
A Prospective Observational Study of TPIAT
Separate and Combined Extrapancreatic Effects of GIP and GLP-1
Separate and Combined Extrapancreatic Effects of the Incretin Hormones
A Phase II Trial of Lanreotide for the Prevention of Postoperative Pancreatic Fistula
Evaluation of the Impact of Pancreatectomy on Systemic Immunity
Bionic Pancreas in Children With Hyperinsulinism and Post-Pancreatectomy Diabetes
Glucose Metabolism After Partial Pancreatectomy
Collection of Human Liver Biopsy and Whole Blood Samples From T1DM, TP or PP Patients for Potential Use for Insulin Producing Cells in Future Clinical Studies